JOHN H ABELES Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN H ABELES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN H ABELES. JOHN H ABELES is in Medite Cancer Diagnostics, Inc. ($MDIT) and Director in ORYX TECHNOLOGY CORP ($ORYX) and Director in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in Neurotrope, Inc. ($NTRP).
Latest Insider Trading Transactions of JOHN H ABELES
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DUSA, MDIT, NTRP, ORYX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 23 2018 | MDIT | Medite Cancer Diag ... | ABELES JOHN H | Buy | P | 0.08 | 266,667 | 20,000 | 1,566,852 | 1.3 M to 1.6 M (+20.51 %) | |
Oct 23 2018 | MDIT | Medite Cancer Diag ... | ABELES JOHN H | Buy | J | 0.00 | 40,000 | 0 | 1,300,185 | 1.3 M to 1.3 M (+3.17 %) | |
Jul 10 2018 | MDIT | Medite Cancer Diag ... | ABELES JOHN H | Buy | P | 0.08 | 400,000 | 30,000 | 2,608,381 | 2.2 M to 2.6 M (+18.11 %) | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | A | 1.50 | 166,667 | 250,001 | 166,667 | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | A | 1.00 | 166,667 | 166,667 | 166,667 | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | A | 1.25 | 166,667 | 208,334 | 166,667 | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | A | 0.80 | 166,667 | 133,334 | 166,667 | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | A | 0.80 | 166,667 | 133,334 | 166,667 | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | A | 0.00 | 1,667 | 0 | 166,667 | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | P | 1.50 | 208,334 | 312,501 | 208,334 | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | P | 1.00 | 208,334 | 208,334 | 208,334 | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | P | 1.25 | 208,334 | 260,418 | 208,334 | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | P | 0.80 | 208,334 | 166,667 | 208,334 | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | P | 0.80 | 208,334 | 166,667 | 208,334 | |
Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | P | 0.00 | 2,083 | 0 | 208,334 | |
Jul 01 2010 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | A | 2.15 | 10,000 | 21,500 | 10,000 | |
Dec 18 2009 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Buy | P | 1.30 | 20,000 | 25,960 | 77,000 | 57 K to 77 K (+35.09 %) |
Dec 18 2009 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Buy | P | 1.26 | 20,000 | 25,120 | 57,000 | 37 K to 57 K (+54.05 %) |
Jul 01 2009 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | A | 1.10 | 10,000 | 11,000 | 10,000 | |
Mar 17 2009 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Grant | A | 0.00 | 7,500 | 0 | 12,500 | 5 K to 12.5 K (+150.00 %) |
Jul 01 2008 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | A | 2.01 | 10,000 | 20,100 | 10,000 | |
Nov 14 2007 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Buy | P | 2.05 | 5,000 | 10,250 | 114,500 | 109.5 K to 114.5 K (+4.57 %) |
Jul 02 2007 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | A | 3.08 | 10,000 | 30,800 | 10,000 | |
Jul 05 2006 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | A | 5.65 | 10,000 | 56,500 | 10,000 | |
Dec 08 2005 | ORYX | ORYX TECHNOLOGY CO ... | ABELES JOHN H | Director | Buy | J | 1.63 | 4,000 | 6,510 | 2,458 | -1,542 to 2.5 K (-259.40 %) |
Jul 22 2005 | ORYX | ORYX TECHNOLOGY CO ... | ABELES JOHN H | Director | Option Exercise | J | 5.93 | 2,278 | 13,497 | 0 | |
Jul 22 2005 | ORYX | ORYX TECHNOLOGY CO ... | ABELES JOHN H | Director | Option Exercise | J | 6.00 | 5,000 | 30,000 | 0 | |
Jul 22 2005 | ORYX | ORYX TECHNOLOGY CO ... | ABELES JOHN H | Director | Buy | P | 1.50 | 7,278 | 10,917 | 83,220 | 75.9 K to 83.2 K (+9.58 %) |
Jul 01 2005 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | A | 9.30 | 10,000 | 93,000 | 10,000 | |
Jan 20 2005 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | M | 6.94 | 10,000 | 69,375 | 0 | |
Jan 20 2005 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | M | 2.51 | 10,000 | 25,100 | 0 | |
Jan 20 2005 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Sell | S | 15.00 | 10,000 | 150,030 | 10,000 | 20 K to 10 K (-50.00 %) |
Jan 20 2005 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Buy | M | 6.94 | 10,000 | 69,375 | 20,000 | 10 K to 20 K (+100.00 %) |
Jan 20 2005 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Buy | M | 2.51 | 10,000 | 25,100 | 10,000 | 0 to 10 K |
Jul 01 2004 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | A | 9.50 | 10,000 | 95,000 | 10,000 | |
Jul 29 2003 | ORYX | ORYX TECHNOLOGY CO ... | ABELES JOHN H | Director | Option Exercise | A | 3.00 | 5,000 | 15,000 | 5,000 | |
Jul 29 2003 | ORYX | ORYX TECHNOLOGY CO ... | ABELES JOHN H | Director | Buy | P | 1.00 | 20,000 | 20,000 | 20,000 | 0 to 20 K |
Feb 02 2002 | ORYX | ORYX TECHNOLOGY CO ... | ABELES JOHN H | Director | Option Exercise | P | 6.00 | 5,000 | 30,000 | 5,000 | |
Feb 02 2002 | ORYX | ORYX TECHNOLOGY CO ... | ABELES JOHN H | Director | Buy | P | 2.50 | 20,000 | 50,000 | 75,942 | 55.9 K to 75.9 K (+35.75 %) |
Page: 1